Solriamfetol: First Global Approval

This article summarizes the milestones in the development of solriamfetol leading to this first approval as a treatment for excessive daytime sleepi ness associated with narcolepsy and OSA.
Source: Drugs - Category: Drugs & Pharmacology Source Type: research